Techniscan launches 3-D ultrasound clinical study at the University of Freiburg breast

Radiologists involved in the study will use the Freiburg Techniscan Imaging Network, which provides the ability to archive, store and retrieve relevant images and UMA anonymous medical records and discuss and compare their results with other researchers.Italian company Esaote Medical Imaging Techniscan worked with system development and support efforts Techniscan AMU in Europe and Italy. “The hot bath ultrasound has been developed with the science and the technological revolution,” said Dr. Louis Satragni, R & D and Strategic Marketing Director General of Esaote. “We look forward to seeing the results of clinical trials and a long and successful partnership with Techniscan”.

“Our vision is to start creating a database of thousands of images of the breast and its data anonymous,” said Dave Robinson, CEO of Techniscan, Inc. “This database will include scientific anonymous mammograms, breast MRI images of the AMU, along with information of Pathology and others, to provide researchers around the world an unprecedented opportunity to study. The concept is simple, but revolutionary in the healthcare system and represents an important competitive advantage of Techniscan system. ”

Techniscan warm bath of ultrasound (UMA) technology is designed for the ultrasonic technique used in a tub of hot water, to capture 3-D images of the breast as a woman lying on a table.

Esaote is one of the most dynamic medical images in the world specializing in ultrasound systems for high performance and is a key investor Techniscan, Esaote Inc premium hand-held ultrasound system, the XVG MyLab 70, Techniscan system is integrated into an ultrasonic bath to warm to provide both an automatic reflex of images and help in the bosom of the hand-guided biopsy. As a key OEM supplier for the system of the AMU, Esaote provides Techniscan with the support of planning, regulatory and production initiatives.

Headquartered in Salt Lake City, Utah, Techniscan, Inc. is a medical device company specializing in developing and commercializing a noninvasive imaging tool designed to provide physicians with images of the human automated breast ultrasound. UMA Techniscan the imaging device is limited by U.S. law to use in the studio unless and until approved by the FDA.

Techniscan, Inc. (OTC Bulletin Board: TSNI) (“Techniscan” or the “Company”), a medical device company specializing in the development and commercialization of an automated 3-D imaging system for breast ultrasound, announced in collaboration with the University Medical Center Freiburg, Germany, has begun a clinical trial to evaluate the clinical utility of ultrasound Techniscan the hot tub.

Physicians can acquire a total of at least 150 women in the three defined groups: those with normal mammogram results, those with benign lesions known, and those with known malignancies. The study provides a direct comparison of the images against UMA Techniscan mammography, magnetic resonance imaging and portable ultrasound to assess directly the ability of the UMA by providing comparative results of the diagnosis.